Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
What Happened This Week: AMTD Revives Meme Action, Alibaba Sparks Speculation
12:20pm, Saturday, 06'th Aug 2022 Investing.com
Analyst Ratings for Amgen
09:25pm, Friday, 05'th Aug 2022 Benzinga
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
4
0
0
Last 30D
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
01:45pm, Friday, 05'th Aug 2022 Zacks Investment Research
Amgen (AMGN) beats Q2 estimates for earnings and sales. It offers to buy ChemoCentryx (CCXI) for $3.7 billion.
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
11:17am, Friday, 05'th Aug 2022
Amgen (AMGN) beats Q2 estimates for earnings and sales. It offers to buy ChemoCentryx (CCXI) for $3.7 billion.
Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates
09:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Amgen (AMGN) delivered earnings and revenue surprises of 5.68% and 0.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Amgen Inc. (AMGN) CEO Bob Bradway on Q2 2022 Results - Earnings Call Transcript
09:05pm, Thursday, 04'th Aug 2022
Amgen Inc. (NASDAQ:AMGN ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO Murdo Gordon - EVP, G
Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates
06:48pm, Thursday, 04'th Aug 2022
Amgen (AMGN) delivered earnings and revenue surprises of 5.68% and 0.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ChemoCentrix Spikes 110% on Amgen Acquisition Deal
06:10pm, Thursday, 04'th Aug 2022
On Thursday, shares of ChemoCentryx Inc. ( CCXI , Financial) shot up more than 110% before closing the day at $50.43 on the news that the small-cap biotech company has entered into an agreement to be
Why ChemoCentryx Stock Is On Fire Today
02:08pm, Thursday, 04'th Aug 2022 The Motley Fool
The rare-disease specialist is being bought out at a sizable premium.
ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition
11:30am, Thursday, 04'th Aug 2022
Source: Shutterstock ChemoCentryx (NASDAQ: CCXI ) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (NASDAQ: AMGN ). This deal has Amgen agreeing to ac
Why Amgen (AMGN) Is Buying ChemoCentryx (CCXI) For $4 Billion In Cash
10:39am, Thursday, 04'th Aug 2022
Amgen (AMGN) is buying ChemoCentryx (CCXI) for $4 billion in cash. These are the details.
Amgen to gain rare-disease drug in $3.7 billion acquisition of ChemoCentryx
08:24am, Thursday, 04'th Aug 2022
Amgen Inc. AMGN, +1.32% said Thursday it plans to buy ChemoCentryx Inc. CCXI, +3.61% for $3.7 billion in cash. The deal will give Amgen access to Tavneos, a treatment for ANCA-associated vasculitis th
Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More
01:48pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Let us look at four large drug and biotech companies, AMGN, VRTX, LLY, NVO, which are gearing up for their earnings release.
Famed "Big Short" Investor Loves This Multibillion-Dollar Company -- Should You?
12:32pm, Wednesday, 03'rd Aug 2022 The Motley Fool
Will Bristol-Myers Squibbs' pipeline and newly approved drugs overcome its expiring patents?
CA declares monkeypox emergency, Amgen disputes tax allegations,
12:08pm, Tuesday, 02'nd Aug 2022
Yahoo Finance anchor Julie Hyman reports the latest notable business headlines include Amgen disputing allegations that it underreported taxes, BP raising its dividend after reporting blowout earnings
